Correlation Between Spyre Therapeutics and Senmiao Technology

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Senmiao Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Senmiao Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and Senmiao Technology, you can compare the effects of market volatilities on Spyre Therapeutics and Senmiao Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Senmiao Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Senmiao Technology.

Diversification Opportunities for Spyre Therapeutics and Senmiao Technology

-0.34

Correlation Coefficient

Spyre Therapeutics  Senmiao Technology

Very good diversification

The 3 months correlation between Spyre and Senmiao is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Senmiao Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Senmiao Technology and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Senmiao Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Senmiao Technology has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Senmiao Technology go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and Senmiao Technology

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the Senmiao Technology. But the stock apears to be less risky and, when comparing its historical volatility, Spyre Therapeutics is 1.02 times less risky than Senmiao Technology. The stock trades about -0.43 of its potential returns per unit of risk. The Senmiao Technology is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest  97.00  in Senmiao Technology on September 12, 2024 and sell it today you would lose (8.90) from holding Senmiao Technology or give up 9.18% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Spyre Therapeutics  vs.  Senmiao Technology

Spyre Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Spyre Therapeutics is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Senmiao Technology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Senmiao Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Spyre Therapeutics and Senmiao Technology

The main advantage of trading using opposite Spyre Therapeutics and Senmiao Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Senmiao Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Senmiao Technology will offset losses from the drop in Senmiao Technology's long position.

The idea behind Spyre Therapeutics and Senmiao Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.